Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Https://sterlingmedicaldevices.com/thought-leadership/is-the-fda-de-novo-pathway-the-right-medical-device-regulatory-pathway-for-you/#:~:text=The%20De%20Novo%20pathway%2C%20introduced,predicate%2C%20or%20no%20substantial%20equivalence.
Https://healthinnovationnenc.org.uk/what-we-do/improving-population-health/cardiovascular-disease-prevention/familial-hypercholesterolaemia-fh/
Lipid inCode® is the first commercial polygenic test for CVD to be implemented by the NHS. Read about how the AHSN NENC will now implement the use of the test in the Darlington PCN and community practice representing over 100,000 patients in the North of England.
The Sh*ts bought Glanco for hefty sum from their mates, used our money to built up the business and then sold it back to the same owners (their mates) for a euro.
Following the receipt of the Report, the Prime Minister of Azerbaijan issued a press release saying that based on the Report the Gedabek plant can gradually restart operations. The restart of operations will take place in accordance with a timetable to be agreed with the Government. The Company and the Government will also work together to implement Micon's recommendations for the Gedabek operation contained in the Report.
Interesting listen.
I get a feeling management are very conservative with their projections.
Fund raise coming sooner rather than later, approx 8m but it’s potentially the last raise needed.
Addressable market is huge!
RA International Group PLC (AIM: RAI), a specialist provider of complex and integrated remote site services to organisations globally, is pleased to announce the award of a strategically significant new contract with the UK's Foreign, Commonwealth and Development Office (FCDO). The minimum two-year global framework agreement will see RA provide operational support capability funded through the Conflict, Stability and Security Fund (CSSF), commencing 18 September 2023.
The services which RA will most likely provide will be funded from a sub-lot allocated to the CSSF valued, in aggregate, at a maximum of GBP 375m (over 2 years). They relate to "providing and delivering operational and technical equipment to organisations in hostile environments in a Human Rights compliant manner", and include the following sub-themes:
Looks like the seller is out.
A bunch of C**ts.
Used shareholder money to grow Glanaco and now return it back to original owners. No doubt the dodgy BOD are benefiting from this transaction.
The RNS mentions 2022 results but forgets to mention the large wins in 2023.
Https://www.itv.com/news/2023-07-14/genetic-testing-could-bring-in-new-age-of-diagnostics-in-nhs
Looks undervalued. Trading below cash levels. Took a small position for a trade.
Plus this
' is intended to complement the expected offtake arrangements being finalised with the global multi-national company ("MNC"), which is expected to complete its due diligence shortly.'